Vibhavadi Medical Center Toekomstige groei
Future criteriumcontroles 3/6
Vibhavadi Medical Center is forecast to grow earnings and revenue by 35.6% and 2.7% per annum respectively while EPS is expected to grow by 37.1% per annum.
Belangrijke informatie
35.6%
Groei van de winst
37.1%
Groei van de winst per aandeel
Healthcare winstgroei | 10.7% |
Inkomstengroei | 2.7% |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | Low |
Laatst bijgewerkt | 19 Jun 2024 |
Recente toekomstige groei-updates
Recent updates
Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2025 | 8,948 | 1,192 | 1,170 | 1,796 | 1 |
12/31/2024 | 8,522 | 1,076 | 944 | 1,213 | 1 |
6/30/2024 | 8,640 | 621 | 1,257 | 1,814 | N/A |
3/31/2024 | 8,544 | 659 | 1,358 | 1,856 | N/A |
12/31/2023 | 8,318 | 865 | 1,296 | 1,819 | N/A |
9/30/2023 | 8,075 | 834 | 1,447 | 1,880 | N/A |
6/30/2023 | 8,095 | 889 | 1,598 | 1,972 | N/A |
3/31/2023 | 8,407 | 1,070 | 1,644 | 2,066 | N/A |
12/31/2022 | 8,767 | 1,376 | 1,540 | 1,970 | N/A |
9/30/2022 | 9,221 | 1,847 | 1,430 | 2,068 | N/A |
6/30/2022 | 8,950 | 2,188 | 1,005 | 1,707 | N/A |
3/31/2022 | 8,254 | 2,106 | 861 | 1,707 | N/A |
12/31/2021 | 7,481 | 1,843 | 707 | 1,672 | N/A |
9/30/2021 | 6,738 | 1,454 | 321 | 1,425 | N/A |
6/30/2021 | 6,366 | 839 | 76 | 1,399 | N/A |
3/31/2021 | 6,018 | 522 | -350 | 1,092 | N/A |
12/31/2020 | 6,148 | 465 | -402 | 1,095 | N/A |
9/30/2020 | 6,210 | 321 | -331 | 1,197 | N/A |
6/30/2020 | 6,400 | 643 | 106 | 1,418 | N/A |
3/31/2020 | 6,772 | 835 | 89 | 1,571 | N/A |
12/31/2019 | 6,662 | 809 | 168 | 1,527 | N/A |
9/30/2019 | 6,560 | 754 | 350 | 1,302 | N/A |
6/30/2019 | 6,507 | 598 | 326 | 1,254 | N/A |
3/31/2019 | 6,467 | 638 | 743 | 1,235 | N/A |
12/31/2018 | 6,570 | 724 | 717 | 1,198 | N/A |
9/30/2018 | 6,574 | 841 | 891 | 1,405 | N/A |
6/30/2018 | 6,594 | 917 | 1,042 | 1,521 | N/A |
3/31/2018 | 6,442 | 910 | N/A | 1,405 | N/A |
12/31/2017 | 6,196 | 869 | N/A | 1,376 | N/A |
9/30/2017 | 6,069 | 842 | N/A | 1,251 | N/A |
6/30/2017 | 5,913 | 771 | N/A | 1,240 | N/A |
3/31/2017 | 5,824 | 687 | N/A | 1,215 | N/A |
12/31/2016 | 5,824 | 679 | N/A | 1,250 | N/A |
9/30/2016 | 5,752 | 712 | N/A | 1,401 | N/A |
6/30/2016 | 5,639 | 687 | N/A | 1,210 | N/A |
3/31/2016 | 5,518 | 702 | N/A | 1,264 | N/A |
12/31/2015 | 5,469 | 736 | N/A | 1,304 | N/A |
9/30/2015 | 5,320 | 679 | N/A | 1,030 | N/A |
6/30/2015 | 5,148 | 614 | N/A | 1,090 | N/A |
3/31/2015 | 5,062 | 619 | N/A | 1,067 | N/A |
12/31/2014 | 4,960 | 596 | N/A | 950 | N/A |
9/30/2014 | 4,834 | 555 | N/A | 1,033 | N/A |
6/30/2014 | 4,877 | 653 | N/A | 1,041 | N/A |
3/31/2014 | 4,769 | 613 | N/A | 1,031 | N/A |
12/31/2013 | 4,570 | 546 | N/A | 979 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: VIBHA's forecast earnings growth (35.6% per year) is above the savings rate (2%).
Winst versus markt: VIBHA's earnings (35.6% per year) are forecast to grow faster than the TH market (15.2% per year).
Hoge groeiwinsten: VIBHA's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: VIBHA's revenue (2.7% per year) is forecast to grow slower than the TH market (6.4% per year).
Hoge groei-inkomsten: VIBHA's revenue (2.7% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if VIBHA's Return on Equity is forecast to be high in 3 years time